Floatz logo

Pregabalin

Fibromyalgia

Yung Shin Pharm. Ind. Co., Ltd.Small moleculePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Fibromyalgia cohort.

Asset / SponsorPhaseRating
Duloxetine
Cukurova University
Phase 4BBB
PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)-
Taipei Veterans General Hospital, Taiwan
Phase 4BB
LIDOCAINE
Peking University Third Hospital
Phase 2BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Good Samaritan Regional Medical Center, Oregon
Phase 3B
Zonisamide
University of Pittsburgh
Phase 4B

View all 33 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant
A
Indicative ·
82 / 100
View asset →
peripheral neuropathyDormant
A
Indicative ·
82 / 100
View asset →
Depressive Disorder, MajorDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →